Document is current
Any future updates will be listed below
-
Authors
Cen, Yelei
Xia, Caixia
Yao, Shouhan
Weng, Xinyu
Qi, Jinjin
Lou, Guohua
Zheng, Min
Liu, Yanning
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82270624)
National Natural Science Foundation of China (U24A20773)
National Natural Science Foundation of China (82370613)
National Key Research and Development Program of China (2023YFC2306800)
Independent Task of State Key Laboratory for Diagnosis and Treatment of Infectious Diseases (zz202314)
- License Information
-
More Information
Article History
Received: 1 September 2025
Accepted: 14 November 2025
First Online: 24 November 2025
Declarations
:
: The animal study was performed according to the institutional animal care and use committee of the First Affiliated Hospital, Zhejiang University School of Medicine and approved (2023 − 702) by the Tab of Animal Experimental Ethical Inspection of the First Affiliated Hospital, Zhejiang University School of Medicine (date of approval: February 22, 2023). Title of the approved project is “Study on the role and mechanism of TREM2-related efferocytosis in the treatment of liver failure with AMSC-exo”. This work has been reported in line with the ARRIVE guidelines 2.0. There were no ethical conflicts associated with this manuscript.
: The authors declare no competing interests.
